Eli Lilly (NYSE:LLY) announced that its financial results for Q1 2025, prepared under the U.S. generally accepted accounting ...

Across Wall Street, 44 publicly traded companies were upgraded Tuesday to an equivalent rating of "buy" or "neutral." ...

The Dow and S&P 500 wavered between gains and losses at midday Wednesday amid heightened volatility after the U.S. imposed ...

Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull ... paying for weight loss drugs such as Eli Lilly’s Zepbound. Danish drugmaker Novo Nordisk ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... “Whether you think it’s good policy or ...

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Arrowstreet Capital Limited Partnership decreased its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 99.1% during the 4th quarter, according to the company in its most recent filing ...

The trial results are among the pharmaceutical industry's most critical and closely watched of the year, as they bring Eli Lilly's drug ... drug market to hit Wall Street's lofty forecasts.